-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B/idABvOh5JkA/HbEf+SwlM1VU3Dmkpm2Iid0hG9Z28MOeMGMMwaJ23HMJMnbweD 6vI+iDyJVxC7KYlhcGobSQ== 0000891092-04-002676.txt : 20040527 0000891092-04-002676.hdr.sgml : 20040527 20040527122849 ACCESSION NUMBER: 0000891092-04-002676 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040525 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHOTOMEDEX INC CENTRAL INDEX KEY: 0000711665 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 592858100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11635 FILM NUMBER: 04834270 BUSINESS ADDRESS: STREET 1: FIVE RADNOR CORPORATE CENTER STREET 2: SUITE 470 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 4072814103 MAIL ADDRESS: STREET 1: FIVE RADNOR CORPORATE CENTER STREET 2: SUITE 470 CITY: RADNOR STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: LASER PHOTONICS INC DATE OF NAME CHANGE: 19920703 8-K 1 e18051_8k.txt FORM 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 25, 2004 PhotoMedex, Inc. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 0-11635 59-2858100 - ---------------------------- ---------------- ------------------- (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 147 Keystone Drive, Montgomeryville, PA 18936 - ---------------------------------------- ------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code 215.619.3600 - -------------------------------------------------------------------------------- (Former name or former address if changed since last report) ================================================================================ Item 9. Regulation FD Disclosure On May 25, 2004, the Registrant announced that Aetna, a private health plan, had approved for reimbursement procedures using the XTRAC(R) excimer laser to treat psoriasis. The Information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12 (a) (2) of the Securities Act of 1933, as amended. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PhotoMedex, Inc. Date: May 27, 2004 By: /s/ Dennis M. McGrath --------------------------- Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Subject Matter Press release of PhotoMedex, Inc. 99.1 PhotoMedex Press Release dated May 25, 2004, reporting the announcement that Aetna Adopts Reimbursement for PhotoMedex XTRAC(R) 3 EX-99.1 2 e18051ex99_1.txt PRESS RELEASE Exhibit 99.1 Aetna Adopts Reimbursement for PhotoMedex XTRAC(R) MONTGOMERYVILLE, Pa., and CARLSBAD, Calif., May 25 /PRNewswire-FirstCall/ - -- PhotoMedex (Nasdaq: PHMD) today announced that Aetna, one of the nation's leading providers of healthcare benefits, has adopted a medical policy approving payment for medically necessary treatment of mild to moderate psoriasis using the PhotoMedex XTRAC(R) laser system. Aetna provides benefits through employers in all 50 states, with products and services specifically targeted to small, mid-sized and large multi-state national employers, serving more Fortune 1,000 companies than any of its competitors. The company also serves individuals and Medicare beneficiaries in certain markets. Jeff O'Donnell, PhotoMedex' CEO said, "We are pleased to announce that Aetna has joined the ranks of those prestigious healthcare insurers that have recognized the XTRAC as an appropriate reimbursable therapy by including it in its subscriber offerings. Aetna subscribers will now have the opportunity to avail themselves of this clinically superior treatment for mild to moderate psoriasis. Aetna is one of the Nation's leaders in the healthcare insurance industry and we believe this favorable decision will continue to support and encourage industry peers to follow suit." Aetna's nationwide network includes more than 600,000 healthcare service providers, including over 370,000 primary care and specialist physicians and 3,783 hospitals. The medical policy covering the XTRAC(R) can be found at http://www.aetna.com/cpb/data/CPBA0577.html. About PhotoMedex: PhotoMedex provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The company is a leader in the development, manufacturing and marketing of medical laser products and services. Some portions of this release, particularly those describing PhotoMedex' strategies contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1993, as amended and Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its results. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by PhotoMedex or its subsidiaries that the forward-looking statements will be achieved. For further information, please contact: investors, Matt Clawson of Allen & Caron, +1-949-474-4300, matt@allencaron.com, for PhotoMedex, Inc.; or Dennis McGrath, CFO of PhotoMedex, Inc., +1-215-619-3287, info@photomedex.com SOURCE PhotoMedex -0- 05/25/2004 /CONTACT: investors, Matt Clawson of Allen & Caron, +1-949-474-4300, matt@allencaron.com, for PhotoMedex, Inc.; or Dennis McGrath, CFO of PhotoMedex, Inc., +1-215-619-3287, info@photomedex.com/ /Web site: http://www.aetna.com/cpb/data/CPBA0577.html / (PHMD) CO: Aetna; PhotoMedex ST: California, Pennsylvania IN: BIO MTC HEA SPM SU: -----END PRIVACY-ENHANCED MESSAGE-----